Search

Jinhua C Xiang

from Iowa City, IA
Age ~61
Get Report
Also known as:
Jin Hua Xiang, Jinhua Xing, Jin-Hua Xiang, Junhua Xiang, Xiang Jinhua, Xiang Jin-Hua
Phone and address:
314 Butternut Ln, Iowa City, IA 52246
Related to:
Yong S Lee, 81Jing Xiong, 45Byeng D Youn, 54Eun Y Woo, 58Ja L Jung, 80
Connected to:
Andrew Xiang, 27Bing H Xiang, 66Chong Xiang, 50Gabriel Xiang, 66Hua L Xiang, 80Jianxing Xiang, 38Kai L Xiang, 63Lee Xiang, 58Ling Z Xiang, 55Luchan Xiang, 36

Jinhua Xiang Phones & Addresses

  • 314 Butternut Ln, Iowa City, IA 52246
  • 2601 Walden Rd, Iowa City, IA 52246 (319) 358-9176
  • 334 Hawkeye Dr, Iowa City, IA 52246

Resumes

Resumes

Jinhua Xiang Photo 1

Scientist

View page
Location:
Iowa City, IA
Industry:
Research
Work:
University of Iowa
Scientist
Jinhua Xiang Photo 2

Jinhua Xiang

View page
Location:
United States
Jinhua Xiang Photo 3

Jinhua Xiang

View page

Publications

Us Patents

Gb Virus C And Methods Of Treating Viral Infections

View page
US Patent:
7291723, Nov 6, 2007
Filed:
Oct 24, 2003
Appl. No.:
10/693258
Inventors:
Jack T. Stapleton - Iowa City IA, US
Jinhua Xiang - Iowa City IA, US
Sarah George - St. Louis MO, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
C07H 21/04
US Classification:
536 2372, 4241891, 4242181, 435 691, 4353201, 536 231
Abstract:
The present application provides GB virus C sequences (GBV-C or hepatitis G virus) and methods of using the sequences.

Flavivirus Ns5A Proteins For The Treatment Of Hiv

View page
US Patent:
7951531, May 31, 2011
Filed:
Feb 1, 2006
Appl. No.:
11/345662
Inventors:
Jack T. Stapleton - Iowa City IA, US
Jinhua Xiang - Iowa City IA, US
Qing Chang - Iowa City IA, US
James McLinden - Coralville IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
C12Q 1/70
A61K 39/21
A61K 39/29
US Classification:
435 5, 4242081, 4242281
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving a-GBV-C NS5A peptide or polypeptide for inhibiting and treating HIV infections.

Flavivirus Ns5A Proteins For The Treatment Of Hiv

View page
US Patent:
8268778, Sep 18, 2012
Filed:
Mar 20, 2008
Appl. No.:
12/532064
Inventors:
James McLinden - Coralville IA, US
Jinhua Xiang - Iowa City IA, US
Jack T. Stapleton - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A01N 37/18
A61K 38/00
A61P 31/18
US Classification:
514 38, 514 39
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving a -GBV-C NS5A peptide or polypeptide for inhibiting and treating HIV infections.

Full-Length Gb Virus C (Hepatitis G Virus) Rna Transcripts Are Infectious In Primary Cd4 Positive T Cells And Methods Of Treating Hiv

View page
US Patent:
20030170870, Sep 11, 2003
Filed:
Apr 5, 2001
Appl. No.:
09/828498
Inventors:
Jinhua Xiang - Iowa City IA, US
Sabina Wunschmann - Coralville IA, US
Warren Schmidt - Oxford IA, US
Jack Stapleton - Iowa City IA, US
International Classification:
C12N007/00
C07H021/04
A61K048/00
A01N063/00
C12N015/09
US Classification:
435/235100, 424/093210, 536/023720, 424/228100, 536/023100, 536/023500, 435/320100
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a recently described flavivirus that frequently leads to chronic viremia in humans. Although associated with acute post-transfusion hepatitis, it is not clear if GBV-C is pathogenic for humans. A full-length cDNA was constructed from the plasma of a person with chronic GBV-C viremia. Peripheral blood mononuclear cells (PBMCs) transfected with full-length RNA transcripts from this GBV-C clone resulted in viral replication, demonstrating an isolated infectious GBV-C nucleic acid molecule. In addition to composition involving an isolated infectious GBV-C nucleic acid molecule, the present invention concerns methods of inhibiting and treating HIV infections.

Gb Virus C (Hepatitis G Virus) For The Treatment Of Hiv

View page
US Patent:
20050118181, Jun 2, 2005
Filed:
Jun 4, 2004
Appl. No.:
10/862061
Inventors:
Jack Stapleton - Iowa City IA, US
Jinhua Xiang - Iowa City IA, US
Donna Klinzman - Coralville IA, US
James McLinden - Coralville IA, US
International Classification:
A61K039/42
C12Q001/70
US Classification:
424160100, 435005000
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.

Gb Virus C (Hepatitis G Virus) For The Treatment Of Hiv

View page
US Patent:
20090010932, Jan 8, 2009
Filed:
Jul 24, 2008
Appl. No.:
12/179399
Inventors:
JACK T. STAPLETON - Iowa City IA, US
Jinhua Xiang - Iowa City IA, US
Donna Klinzman - Coralville IA, US
James H. McLinden - Coralville IA, US
International Classification:
C07K 16/08
A61K 39/395
A61K 31/7072
A61K 31/711
A61K 39/29
US Classification:
4241331, 5303871, 53038822, 5303873, 4241591, 4241471, 514 51, 4242181, 4241891, 435 696
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.

Viral Proteins As Immunomodulatory Agents And Vaccine Components

View page
US Patent:
20160067331, Mar 10, 2016
Filed:
Mar 14, 2014
Appl. No.:
14/773855
Inventors:
- Iowa City IA, US
Nirjal BHATTARAI - Coralville IA, US
Jinhua XIANG - Iowa City IA, US
James H. MCLINDEN - Coralville IA, US
International Classification:
A61K 39/29
A61K 39/21
A61K 39/145
A61K 39/12
A61K 45/06
C12N 7/00
Abstract:
The invention provides compositions and methods involving viral envelope polypeptides and peptides for use in modulating immune responses, including inhibition inflammation related to pathogenic T-cell activation. In addition, modification of the viral sequences responsible for modulating immune response provides for improved vaccine formulations.

Gb Virus C (Hepatitis G Virus) E2 Glycoprotein As An Immunomodulatory Agent

View page
US Patent:
20150071955, Mar 12, 2015
Filed:
Mar 13, 2013
Appl. No.:
14/384775
Inventors:
- Iowa City IA, US
Nirjal Bhattarai - Coralville IA, US
Jinhua Xiang - Iowa City IA, US
James H. McLinden - Coralville IA, US
Assignee:
THE UNIVERSITY OF IOWA RESEARCH FOUNDATION - Iowa City IA
International Classification:
C07K 14/005
A61K 45/06
A61K 38/16
C12N 7/00
US Classification:
4241891
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving GBV-C E2 polypeptides and peptides for use in modulating immune responses, including inhibition inflammation related to pathogenic T-cell activation.
Control profile
Jinhua C Xiang from Iowa City, IA, age ~61 Get Report